These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2126693

  • 1. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa.
    Bustamante CI, Wharton RC, Wade JC.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1814-5. PubMed ID: 2126693
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
    Gerçeker AA, Gürler B.
    J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F, Quentin C.
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activity of antibiotics against resistant Pseudomonas aeruginosa.
    Fujita J, Negayama K, Takigawa K, Yamagishi Y, Kubo A, Yamaji Y, Takahara J.
    J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection.
    Dudley MN, Blaser J, Gilbert D, Mayer KH, Zinner SH.
    J Infect Dis; 1991 Sep; 164(3):499-506. PubMed ID: 1908000
    [Abstract] [Full Text] [Related]

  • 13. Instability of in vitro resistance to imipenem in Pseudomonas aeruginosa.
    Wolter EJ, Witte W.
    J Basic Microbiol; 1990 Sep; 30(8):617-22. PubMed ID: 2129043
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa.
    Meyer RD, Liu S.
    Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    Mayer I, Nagy E.
    J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.